藍港互動(08267.HK)逾1410萬元售北京聲智1.73%股權
藍港互動(08267.HK)公佈,以總代價約1,175.46萬元人民幣(約1,410.55萬港元),向蘇州慕華股權投資合夥企業、孟慶春及北京棋森集團,出售目標公司北京聲智科技合共約1.73%股權,股權轉讓錄得估計稅前收益約440萬元人民幣(約530萬港元),交易所得款項擬用於集團的一般營運資金。
北京聲智科技主要從事創新聲學技術與人工智能交互技術業務。交割後,集團將不再持有目標公司任何股權,目標公司的資產、負債及財務業績將仍不併入公司的財務報表。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.